CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CardioReGenix focuses on developing advanced gene therapies for cardiovascular diseases, particularly heart failure and myocardial ischemia. The project aims to enhance gene delivery and expression while minimizing immune responses, ultimately improving treatment options for patients.
WHO estimates 17.7 million people die each year from cardiovascular disease (CVD), an estimated 31% of all deaths worldwide.
While progress with conventional treatments is making incremental gains, there remains a need to develop innovative therapeutic approaches.
Gene therapy has gained significant momentum, mainly for treatment of rare monogenetic diseases.
Marketing authorization for gene therapy products has not impacted diseases such as CVD.
Recent, deeper understanding of the molecular/cel…
VRIJE UNIVERSITEIT BRUSSEL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UNIVERSITY OF EASTERN FINLAND (UEF)
Finland, KUOPIO
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, NEWMARKET
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Hannover
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
